Exparel was initially approved in 2011 for single-dose infiltration into a surgical site.
By Pharmaceutical Commerce Staff
Advertisement
Articles by By Pharmaceutical Commerce Staff
Cellular and genetic therapies drive a ‘new paradigm’ for logistics
Packaging designers continue the uphill battle for converting the US pharma industry to unit-dose, compliance-improving packaging
Advertisement
Latest Updated Articles
- Brand enhancement and safety with unit-dose packaging
Published: May 10th 2016 | Updated:
- Pharma’s cold chain is going below zero
Published: July 17th 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Pharma Pulse: Novartis Buys Avidity for $12B, and Trump Threatens 10% Tariff Hike on Canada
2
LogiPharma USA 2025: Pharma Supply Chains Evolve Toward Real-Time Visibility and End-to-End Control
3
Pharma Pulse: Cholesterol Imbalance Tied to Depression Risk, Lilly Acquires Aderum Biotechnologies, and Cambrex Expands API Manufacturing
4
Trump Threatens 10% Tariff Hike on Canadian Imports After Controversial Reagan Ad Airs During World Series
5
